Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Armata Pharmaceuticals to Provide Corporate Update at the 39th Annual Canaccord Genuity Growth Conference
-
Sierra Wireless to Present at Canaccord Genuity's 39th Annual Growth Conference
-
EXFO to present at Canaccord Genuity's Growth Conference
-
ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Homology Medicines to Participate at Upcoming Conferences
-
ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Alder BioPharmaceuticals® to Present at Canaccord Genuity 39th Annual Growth Conference
-
Alder BioPharmaceuticals® to Present at Canaccord Genuity 39th Annual Growth Conference
-
Stoke Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
-
SailPoint to Present at Canaccord Genuity Growth Conference and Oppenheimer Technology, Internet & Communications Conference
-
Vericel to Present at the 39th Annual Canaccord Genuity Growth Conference on Thursday, August 8, 2019
-
Tyme Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference on August 7th, 2019
-
TPI Composites, Inc. to Participate at Upcoming Investor Conferences
-
Tyme Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference on August 7th, 2019
-
Vericel to Present at the 39th Annual Canaccord Genuity Growth Conference on Thursday, August 8, 2019
-
Blade Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
AquaVenture Holdings Limited to Participate at Upcoming Investor Conference
-
The Meet Group to Present at Upcoming Investor Conferences
-
Columbia Care to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Sensata Technologies to Participate in Panel Discussion at Canaccord Genuity’s The Future of Transport Conference
-
Iterum Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Iterum Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Seres Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Aura Biosciences Announces Participation at Upcoming Investor Conferences
-
Bicycle Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
-
EIP Pharma to Present at Canaccord Genuity 39th Annual Growth Conference
-
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
-
MiX Telematics to Present at Upcoming Investor Conferences
-
Dynatrace Inc. (DT) Prices 35.61M Share IPO at $16/Sh
-
Dynatrace Announces Pricing of Initial Public Offering
-
Bandwidth to Present at Upcoming Investor Conferences
-
Turning Point Therapeutics’ CEO to Present at Canaccord Genuity 39th Annual Growth Conference
-
Retrophin to Present at Canaccord Genuity’s 39th Annual Growth Conference
-
Profound Medical to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Turning Point Therapeutics’ CEO to Present at Canaccord Genuity 39th Annual Growth Conference
-
Retrophin to Present at Canaccord Genuity’s 39th Annual Growth Conference
-
Profound Medical to Present at the Canaccord Genuity 39th Annual Growth Conference
-
EverQuote to Participate at Upcoming Investor Conferences
-
EverQuote to Participate at Upcoming Investor Conferences
-
Cortexyme to Present at the Canaccord Genuity Growth Conference on August 7th
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
-
Trupanion to Present at the 2019 Canaccord Genuity Growth Conference
-
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
-
RADA to Present at the Canaccord Genuity Growth Conference
-
CannabisNewsWire Recaps BTN’s Highly Anticipated Cannabis Drinks Expo
-
Alphatec Holdings (ATEC) Prices 10.9M Share Offering of Common Stock at $4.60/Share
-
Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock
-
Quanterix to Present at the Canaccord Genuity 39th Annual Growth Conference
-
MRI Software Acquires AI Real Estate Pioneer LEVERTON to Turn Unstructured Data into Business Insights

